HomeEducationTherapy AreasResourcesMedicinesStarter PacksEvents
Log inRegister

ORFADIN

Patient/Carer Education Resources

How to take ORFADIN (nitisinone) ORAL SUSPENSION (4 mg/mL)

Resources

ORFADIN (nitisinone) ORAL SUSPENSION (4 mg/mL)
Download PDF
Let’s Talk Hereditary tyrosinaemia type 1 (HT-1) and ORFADIN (nitisinone)
Download PDF
How to store ORFADIN (nitisinone)
Download PDF

If you have any questions about treatment with ORFADIN or your condition please contact your healthcare professional(s).

ORFADIN is a trademark of Swedish Orphan Biovitrum AB (publ) and distributed by A. Menarini Australia Pty Ltd.

ORF-AU-1623. Date of Preparation: February 2024